Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty and violations of state law in connection with the proposed sale of BioForm Medical, Inc.(BFRM) referred to as "Bioform" or the "Company" to Merz Pharma Group.
Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.
For comments and feedback: editorial@rttnews.com